SOFTOX SOLUTIONS

SoftOx Solutions AS: FIRST PATIENT DOSED IN SIS-03 PROOF-OF-CONCEPT PATIENT TRIAL

First patient with chronic airway infection dosed, marking initiation of the proof-of-concept phase Oslo, Norway – SoftOx Solutions AS (“SoftOx”), a clinical-stage pharmaceutical company developing a novel anti-infective therapy for airway infections, today announces that the first patient has bee...